- 01/01/2019 - 31/12/2023
- Karine Audouze
- Funded by
- European Union’s Horizon 2020
Exposure to chemical substances that can produce endocrine disrupting effects represents one of the most critical public health threats nowadays. In line with the regulatory framework implemented within the European Union to reduce the levels of endocrine disruptors (EDs) for consumers, new and effective methods for ED testing are needed.
The OBERON project will build an integrated approach for testing and assessment (IATA) to detect endocrine disruptors-related metabolic disorders by developing, improving and validating a battery of test systems.
Other projectsSee Past Projects
Early Genetics Growth/Early Genetics and Lifecourse Epidemiology
Air Pollution, Autism spectrum disorders, and brain imaging in CHildren amongst Europe
Early-life stressors and LifeCycle health
Science and Technology in childhood Obesity Policy
Integrating Environment and Health Research: a Vision for the EU
Advancing Tools for Human Early Lifecourse Exposome Research and Translation
Pre- and post-natal Maternal mental health and newbOrn neurOdevelopment during the COVID-19 panDemic
A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health